You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

Mike Doustdar

since 2025 › Nov › 05 (Wed) @ 11:23 UTC

auto-detected in 3 stories

34 days ago

Novo Nordisk CEO says the drugmaker is more active than ever in seeking out deals ⊕

found 2026 › May › 06 (Wed) @ 16:26 UTC

a story from CNBC ⚠️ › Top News

Novo Nordisk CEO Mike Doustdar says the Ozempic and Wegovy maker is looking for deals more than ever before.

35 days ago

Novo Nordisk CEO: Aim is to expand weight-loss market in U.S. ⊕

found 2026 › May › 06 (Wed) @ 08:58 UTC

a story from CNBC ⚠️ › World News

Charlotte Reed speaks with Mike Doustdar, CEO of Novo Nordisk, after the Danish comapny hiked its 2026 full-year guidance on the back of increased expectations for GLP-1 product sales.

7 months ago

Ozempic maker Novo Nordisk cuts sales and profit forecasts again ⊕

found 2025 › Nov › 05 (Wed) @ 11:05 UTC

a story from The Guardian ⚠️ › International

Downgrade comes as Danish company continues to lose ground to Mounjaro firm Eli Lilly in weight-loss drug market

The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues …

page 1 of 1